Tag: Market Access Research

In pharma, more data doesn’t always mean better answers. Secondary research can tell a team what has happened in a market, such as prescription trends, treatment shares, clinical developments, competitor activity, patient populations, and market size. But when a commercial, medical, development, or market access... Continue reading